Security key
702712100
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)
CUSIP: 702712100
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 3,182,163
- Total 13F shares
- 33,366,974
- Share change
- -2,177,428
- Total reported value
- $31,393,818
- Put/Call ratio
- 0%
- Price per share
- $0.94
- Number of holders
- 53
- Value change
- -$2,067,482
- Number of buys
- 16
- Number of sells
- 28
Report period
Q2 2023
Institutions
53
Top holders
10
PASG full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Passage BIO, Inc. SEC filings
Passage BIO, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 702712100
Recent filing periods:
Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
281%
|
8,931,999
|
$8,554,175 | — | 31 Mar 2023 | |
| Versant Venture Management, LLC |
13F
|
Company |
156%
|
4,959,769
|
$4,749,971 | — | 31 Mar 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
118%
|
3,756,915
|
$3,597,997 | — | 31 Mar 2023 | |
| Lynx1 Capital Management LP |
13F
|
Company |
107%
|
3,407,598
|
$3,263,457 | — | 31 Mar 2023 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
78%
|
2,497,922
|
$2,398,005 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
63%
|
2,017,883
|
$1,932,527 | — | 31 Mar 2023 | |
| Erste Asset Management GmbH |
13F
|
Company |
49%
|
1,560,800
|
$1,496,028 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
33%
|
1,053,999
|
$1,009,416 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
30%
|
964,900
|
$924,000 | — | 31 Mar 2023 | |
| Newtyn Management, LLC |
13F
|
Company |
21%
|
665,221
|
$637,082 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
19%
|
589,008
|
$564,000 | — | 31 Mar 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
18%
|
578,806
|
$553,000 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
12%
|
389,600
|
$373,120 | — | 31 Mar 2023 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
12%
|
367,696
|
$352,000 | — | 31 Mar 2023 | |
| BML Capital Management, LLC |
13F
|
Company |
11%
|
337,467
|
$323,192 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
10%
|
331,914
|
$317,874 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
9.8%
|
310,500
|
$297,366 | — | 31 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.4%
|
300,000
|
$287,310 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
9.4%
|
298,090
|
$285,000 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
9.1%
|
288,926
|
$276,704 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
8.6%
|
274,335
|
$262,731 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
8.5%
|
271,172
|
$259,702 | — | 31 Mar 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
4.1%
|
130,188
|
$125,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
123,873
|
$118,633 | — | 31 Mar 2023 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
3.6%
|
115,000
|
$110,136 | — | 31 Mar 2023 | |
| RBF Capital, LLC |
13F
|
Company |
3.5%
|
110,807
|
$106,120 | — | 31 Mar 2023 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
3.2%
|
101,488
|
$97,195 | — | 31 Mar 2023 | |
| Marquette Asset Management, LLC |
13F
|
Company |
2.7%
|
86,050
|
$82,411 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
2.6%
|
82,895
|
$79,389 | — | 31 Mar 2023 | |
| Vontobel Holding Ltd. |
13F
|
Company |
2.5%
|
80,000
|
$76,616 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.9%
|
60,978
|
$58,399 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.9%
|
60,902
|
$58,326 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
1.9%
|
60,621
|
$58,057 | — | 31 Mar 2023 | |
| Annandale Capital, LLC |
13F
|
Company |
1.7%
|
54,338
|
$52,000 | — | 31 Mar 2023 | |
| HighTower Advisors, LLC |
13F
|
Company |
1.5%
|
47,983
|
$37,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
33,168
|
$31,742 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
1%
|
33,049
|
$32,000 | — | 31 Mar 2023 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.87%
|
27,758
|
$26,584 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.87%
|
27,526
|
$26,362 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.78%
|
24,697
|
$23,660 | — | 31 Mar 2023 | |
| Veritable, L.P. |
13F
|
Company |
0.72%
|
23,045
|
$22,070 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.62%
|
19,723
|
$18,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.57%
|
18,114
|
$17,348 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.52%
|
16,568
|
$15,867 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.43%
|
13,647
|
$13,070 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.41%
|
13,153
|
$12,597 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.32%
|
10,129
|
$9,701 | — | 31 Mar 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.25%
|
8,000
|
$7,664 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.1%
|
3,277
|
$3,138 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
1,607
|
$1,539 | — | 31 Mar 2023 |
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2023
As of 30 Jun 2023,
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,366,974 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Versant Venture Management, LLC, New Leaf Venture Partners, L.L.C., Erste Asset Management GmbH, BML Capital Management, LLC, VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., Lynx1 Capital Management LP, BlackRock Inc., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
55
Q2 2023 holders
53
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.